It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
Does vitamin k2 mk7 cause blood clots
Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus
Vitamin E Improves skin elasticity and may help reduce stretch marks

Pen Dosage Chart Dosage & Protocols Variations Standard GH-Releasing Protocol Dose: 1 2 mg (variant 10 mg pen = 2040 clicks / variant 20 mg pen = 1020 clicks) Duration: 8 12 weeks Frequency: 1 daily Cycle Interval: 8-week rest Goal / Description: Used to stimulate GH and IGF-1 secretion in controlled models Lipolytic Research Protocol Dose: 2 mg (variant 10 mg pen = 40 clicks / variant 20 mg pen = 20 clicks) Duration: 12 16 weeks Frequency: 1 daily Cycle Interval: 8-week rest Goal / Description: Focused on visceral fat and lipid metabolism studies Endocrine Optimization Protocol Dose: 1 mg (variant 10 mg pen = 20 clicks / variant 20 mg pen = 10 clicks) Duration: 8 12 weeks Frequency: Every Other Day Cycle Interval: 4-week rest Goal / Description: Investigates hormonal axis modulation and pituitary response Maintenance Protocol Dose: 1 mg (variant 10 mg pen = 20 clicks / variant 20 mg pen = 10 clicks) Duration: ongoing Frequency: 2 weekly Cycle Interval: 12-week rest Goal / Description: Maintains GH/IGF-1 balance in prolonged research conditions Possible Side Effects Tesamorelin, as a research peptide, may lead to various side effects in experimental models, though not all subjects experience them
